← FDA DRUG APPROVALS
FDA ANDA · ANDA214039
MIGRAINE RELIEF
acetaminophen, aspirin and caffeine
Sponsor: GRANULES
APPLICATION
ANDA214039
TYPE
ANDA
ORIGINAL APPROVAL
2021-02-23
LATEST ACTION
2021-02-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter
Products
ACETAMINOPHEN, ASPIRIN AND CAFFEINEOver-the-counter
ACETAMINOPHEN 250MG, ASPIRIN 250MG, CAFFEINE 65MG · TABLET · ORAL
Approval history
2021-02-23UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.